Kate Munro

Background

About Kate Munro

Senior pharmaceutical executive with broad and deep cross-functional experience with a unique combination spanning clinical development, commercial strategy, communication and business transformation within the pharma/biotech industry, exemplified through various strategic, operational, and global positions in a career spanning two decades at Roche. Extensive experience with direct and indirect management and leadership of teams that have driven the development of early pipeline molecules to key go/no-go decision and investment points. Exceptional skills in structuring problem solving, driving decision-making in ambiguity, and inspiring teams to perform at their best in any situation. Qualified executive coach and leader; passionate about enabling people and teams to solve problems, drive decision making in ambiguity and work creatively to solve complex challenges.Interest in a senior executive role with portfolio/enterprise-based accountabilities and the opportunity to drive informed decision-making, operational execution, growth, and expansion at a diverse company to improve patients’ lives.Expertise & SkillsCommercial strategy and evaluation for pipeline molecules - ONCOLOGYCommercial expertise in leading and collaborating with product and disease area teams to develop tumour and molecule strategies that are competitive, robust and create sustainable value.Drug development – Early pipeline ONCOLOGYAccomplished R&D project leader for early phase oncology projects. Able to set vision and clear direction for the development strategy from candidate selection to Proof of Concept and transition to late development. Ability to lead teams connecting the vision to action.Communication and EngagementClear and inspiring communicator who can work independently or in partnership with leaders to create content and strategies to connect with an organisation to adopt the new ways of working and engage in organisational transformation.Due DiligenceSignificant experience leading cross functional teams in evaluation of in-licensing opportunities. Ability to distil key scientific and technical risks and opportunities then translate into the business case and negotiation terms.